Dr Reddy’s launches antibiotic drug in US

Tags: News
Indian drug maker Dr Reddy’s has launched a generic and low priced version of the brand Avelox which is under marketing license with Merck. For the US market, the brand has total sales of $195 million at the end of one year in December 2013, estimates IMS Health.

The tablets which have Moxifloxacin Hydrochloride as active ingredient would come in 400 mg form. “Presenty, the competition for the drug is low, with only two other generic players, that is Teva and Aurobindo Pharma with approvals. We expect Dr Reddy’s to post sales of $20 million and net profit $5 million for this drug,” said Sarabjit Kour Nangra, senior vice-president (research, pharma) — Angel Broking.

The anti-infective (bacterial infections) drug contains moxifloxacin which is associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is aggravated in patients above 60 years of age and taking corticosteroid drugs, and in patients with kidney, heart or lung transplants. While Bayer Healthcare manufactures the branded drug, Merck distributes it.




  • Everybody who contributes to India’s economic growth must be paid well

    Private sector blue chip companies are known to pay top dollar for top-level talent. Directors in such companies take home hefty pay packets.


Stay informed on our latest news!


Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs


Amita Sharma

Smart cities for the smart citizens

The 21st century has been spoken of as the urban ...

Zehra Naqvi

The prejudiced childhood

Sometimes the most unusual things can remind you of the ...

Bubbles Sabharwal

Women of the world, unite for a change

Last week I attended the Women in the World forum ...


William D. Green

Chairman & CEO, Accenture